𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serum CRP in the diagnosis and treatment of pelvic inflammatory disease

✍ Scribed by M. Hemilä; L. Henriksson; O. Ylikorkala

Publisher
Springer
Year
1987
Tongue
English
Weight
312 KB
Volume
241
Category
Article
ISSN
0003-9128

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epidemiology and diagnosis of acute pelv
Epidemiology and diagnosis of acute pelvic inflammatory disease
✍ Carla Janson 📂 Article 📅 1981 🏛 Elsevier Science 🌐 English ⚖ 299 KB

to almost any of the numerous antibiotics and urinary tract antiseptics that have been approved by the FDA. It is the concentration of antibiotic in the urine and not the blood level that correlates with both clinical and bacteriologic cure. Antimicrobial prophylaxis in those individuals with multip

Ampicillin/sulbactam vs. cefoxitin for t
Ampicillin/sulbactam vs. cefoxitin for the treatment of pelvic inflammatory disease
✍ Joseph G. Jemsek; Frank Harrison 📂 Article 📅 1997 🏛 Hindawi Publishing Corporation 🌐 English ⚖ 82 KB 👁 2 views

Objective: The safety and efficacy of ampicillin plus sulbactam were compared with those of cefoxitin in the treatment of women with pelvic inflammatory disease (PID). Methods: This single-site, randomized, prospective, third-party-blinded, comparative, paralleltreatment study enrolled 93 women wit

Evaluation of ofloxacin in the treatment
Evaluation of ofloxacin in the treatment of laparoscopically documented acute pelvic inflammatory disease (salpingitis)
✍ J.F. Peipert; R.L. Sweet; C.K. Walker; J. Kahn; K. Rielly-Gauvin 📂 Article 📅 1999 🏛 Hindawi Publishing Corporation 🌐 English ⚖ 78 KB 👁 2 views

Objective: To evaluate the safety and efficacy of intravenous and oral ofloxacin monotherapy in the treatment of laparoscopically documented acute pelvic inflammatory disease (PID). Methods: This study was conducted as an open-label, phase-III, uncontrolled, multicenter study. Patients identified w